Showing results (51-60 of 84) with videos related to
Sort By:
Pageof 9
The Journal of Clinical and Aesthetic Dermatology|March 27, 2026
Safety and Efficacy of Aminolevulinic Acid Hydrochloride Topical Gel, 10%, with Red Light in the Treatment of Facial Cutaneous Squamous Cell Carcinoma In SituMark S Nestor, Aysham Chaudry, Robert J Vanaria, et al.Cancer Letters|April 1, 1983
Characterization of NADPH-cytochrome P-450 reductase in a mouse hepatoma cell lineG S Duthu, M S Nestor, J A Berliner, et al.Journal of Cosmetic Dermatology|January 16, 2023
Safety and effectiveness of nano-pulse stimulation™ technology to treat acne vulgaris of the backBruce E Katz, Mark S Nestor, Richard Nuccitelli, et al.Ophthalmology|April 1, 1985
Acquired immune deficiency syndrome. Pathogenic mechanisms of ocular diseaseJ S Pepose, G N Holland, M S Nestor, et al.Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 1, 1985
Composition of cellular infiltrates in rejected human corneal allograftsJ S Pepose, M S Nestor, K M Gardner, et al.Ophthalmology|November 1, 1985
Detection of HLA class I and II antigens in rejected human corneal allograftsJ S Pepose, K M Gardner, M S Nestor, et al.The Journal of Clinical and Aesthetic Dermatology|April 9, 2015
Negative predictive value of pigmented lesion evaluation by multispectral digital skin lesion analysis in a community practice settingRichard R Winkelmann, Darrell S Rigel, Emily Kollmann, et al.The Journal of Clinical and Aesthetic Dermatology|February 15, 2021
A Retrospective Registry Study Evaluating the Long-Term Efficacy and Safety of Superficial Radiation Therapy Following Excision of Keloid ScarsBrian Berman, Mark S Nestor, Michael H Gold, et al.Journal of Drugs in Dermatology : JDD|September 7, 2021
A Randomized, Double-Blind, Active- and Placebo-Controlled Trial Evaluating a Novel Topical Treatment for Keloid ScarsMark S Nestor, Brian Berman, Daniel L Fischer, et al.Journal of Cosmetic Dermatology|February 13, 2024
A review of nonsurgical facial rejuvenation and the role of oxymetazoline hydrochloride ophthalmic solution, 0.1% in periorbital revitalizationDavid J Goldberg, Anneke Andriessen, Michael Gold, et al.Pageof 9